STOCK TITAN
The best stock market news and trading tools all in one place—your must-have platform for investing success.
A must-have platform for stock market information, offering the best tools and updates to supercharge your trading.
Your trusted source for the best stock market news, trading tools, and expert advice. Everything traders need, in one place.

Apollo Endosurgery to Present at Sidoti Conference May 20

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Apollo Endosurgery, Inc. (NASDAQ: APEN) will participate in the Sidoti & Company Virtual Microcap Conference on May 20, 2021. Management will deliver an overview presentation at 10:00 AM EST, with a live and archived webcast accessible via the Apollo website. Additionally, management is available for one-on-one meetings with institutional investors during the conference.

Apollo specializes in innovative, less invasive medical devices for gastrointestinal and bariatric procedures, with its products available in over 75 countries.

Positive
  • None.
Negative
  • None.

AUSTIN, TX / ACCESSWIRE / May 12, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures today announced that it will participate in the Sidoti & Company Virtual Microcap Conference on May 20, 2021. Management will present an overview presentation on Thursday, May 20, at 10:00 am Eastern Standard Time. A live and archive webcast link to the group session will be available in the Investors section of the Apollo website, at www.apolloendo.com.

Additionally, management will also be available for one-on-one meetings with institutional investors and analysts during the dates of the conference. For more information about scheduling a one-on-one meeting with management, please contact a Sidoti institutional sales representative or Matt Kreps, Investor Relations for Apollo Endosurgery, at mkreps@darrowir.com.

About Apollo Endosurgery, Inc.
Apollo Endosurgery, Inc. is a medical technology company focused on development of next-generation, less invasive devices to advance therapeutic endoscopy designed to treat a variety of gastrointestinal conditions including closure of gastrointestinal defects, managing gastrointestinal complications and the treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 75 countries today and include the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, X-Tack™ Endoscopic HeliX Tacking System and the ORBERA® Intragastric Balloon.

Apollo's common stock is traded on the Nasdaq Global Market under the symbol "APEN". For more information regarding Apollo Endosurgery, go to: www.apolloendo.com.

CONTACT:
Apollo Endosurgery, Inc.
Stefanie Cavanaugh, 512-279-5100
investor-relations@apolloendo.com

Darrow Associates Investor Relations
Matt Kreps, 214-597-8200
mkreps@darrowir.com

SOURCE: Apollo Endosurgery, Inc.



View source version on accesswire.com:
https://www.accesswire.com/646341/Apollo-Endosurgery-to-Present-at-Sidoti-Conference-May-20

FAQ

What date is Apollo Endosurgery presenting at the Sidoti Conference?

Apollo Endosurgery will present at the Sidoti Conference on May 20, 2021.

What time will Apollo Endosurgery's presentation take place?

The presentation will take place at 10:00 AM Eastern Standard Time.

Where can I watch the Apollo Endosurgery presentation?

The presentation can be watched live or archived on the Apollo website.

How can investors schedule one-on-one meetings with Apollo's management?

Investors can schedule one-on-one meetings by contacting a Sidoti institutional sales representative or Matt Kreps from Investor Relations.

What is the stock symbol for Apollo Endosurgery?

Apollo Endosurgery trades under the stock symbol APEN.

APEN

NASDAQ:APEN

APEN Rankings

APEN Latest News

APEN Stock Data

579.72M
55.25M
4.29%
63.41%
0.97%
Medical Devices
Healthcare
Link
United States
Austin